It also said in the article I weas reading that immunotherapy for hers2 er positive. Research aimed at improving treatments for HER2-positive breast cancer is growing.

Many HER2-specific treatments work with the immune system to help fight off cancer cells in an approach called immunotherapy. Your body makes proteins called antibodies to block foreign invaders, like viruses, and signal the immune system to destroy potential invaders.

Monoclonal antibodies are a type of immunotherapy used to treat HER2-positive breast cancer. These antibodies are like the ones our bodies make, but they block the HER2 protein. Common monoclonal antibody therapies for HER2-positive breast cancer include:

Margetuximab-cmkb (Margenza)
Pertuzumab (Perjeta)
Trastuzumab (Herceptin)
Although these treatments are usually given through IV infusion in a clinic, pertuzumab and trastuzumab are now combined in a medication called Phesgo that can be administered at home by a health care professional.

Some drugs stop the signaling pathways that happen when tyrosine kinase receptors (like HER2) are active. These include:

Lapatinib (Tykerb)
Neratinib (Nerlynx)
Tucatinib (Tukysa)
Antibody-drug conjugates also are available for HER2-positive breast cancer. These treatments have a monoclonal antibody attached to a drug. After seeing what immuno therapy did to my daughter its scary, but, its also exciting as she is in remission, it was in her brain lung colon ovaries. Research is moving forward every day. Praise the lord... 🙏💃❤️

I am on Letrozole.

Which AI are you on?

I have the same.